147 related articles for article (PubMed ID: 38614983)
1. The preliminary analysis of lymphatic flow around the connective tissues surrounding SMA and SpA elucidates patients' oncological condition in borderline-resectable pancreatic cancer.
Akita H; Asukai K; Mukai Y; Hasegawa S; Omori T; Miyata H; Ohue M; Sakon M; Wada H; Takahashi H
BMC Surg; 2024 Apr; 24(1):107. PubMed ID: 38614983
[TBL] [Abstract][Full Text] [Related]
2. Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Hayami S; Ueno M; Yamaue H
Eur J Surg Oncol; 2021 Oct; 47(10):2586-2594. PubMed ID: 34127329
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.
Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A
World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the degree of lymphatic vessel invasion in locally advanced, surgically resectable pancreatic head cancer: A single center experience.
Morita K; Oshiro H; Mito K; Mieno MN; Tamba-Sakaguchi M; Niki T; Miki A; Koizumi M; Sakuma Y; Komatsubara T; Sata N; Fukushima N
Medicine (Baltimore); 2018 Dec; 97(49):e13466. PubMed ID: 30544433
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract][Full Text] [Related]
6. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
[TBL] [Abstract][Full Text] [Related]
7. Identification of the lymphatic drainage pathways from the pancreatic head guided by indocyanine green fluorescence imaging during pancreaticoduodenectomy.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Uchiyama K; Yamaue H
Dig Surg; 2012; 29(2):132-9. PubMed ID: 22538463
[TBL] [Abstract][Full Text] [Related]
8. ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial.
Okada KI; Kawai M; Hirono S; Sho M; Tani M; Matsumoto I; Yamada S; Amano R; Toyama H; Yamashita YI; Gocho T; Shibuya K; Nagai M; Maehira H; Kamei K; Ohira G; Shirai Y; Takami H; Kimura N; Fukumoto T; Baba H; Kodera Y; Nakao A; Shimokawa T; Katsuda M; Yamaue H
Trials; 2021 Sep; 22(1):633. PubMed ID: 34530885
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of paraaortic lymph node metastases in patients with ductal adenocarcinoma of the pancreatic head.
Petrova E; Mazzella E; Trojan J; Koch C; Schulze F; Bechstein WO; Schnitzbauer AA
Eur J Surg Oncol; 2023 May; 49(5):996-1000. PubMed ID: 36586788
[TBL] [Abstract][Full Text] [Related]
10. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
12. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
[TBL] [Abstract][Full Text] [Related]
14. High GFPT1 expression predicts unfavorable outcomes in patients with resectable pancreatic ductal adenocarcinoma.
Gong Y; Qian Y; Luo G; Liu Y; Wang R; Deng S; Cheng H; Jin K; Ni Q; Yu X; Wu W; Liu C
World J Surg Oncol; 2021 Jan; 19(1):35. PubMed ID: 33517899
[TBL] [Abstract][Full Text] [Related]
15. Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study.
Hashimoto D; Satoi S; Ishida M; Nakagawa K; Kotsuka M; Takagi T; Ryota H; Terai T; Sakaguchi T; Nagai M; Yamaki S; Akahori T; Yamamoto T; Sekimoto M; Sho M
Pancreatology; 2021 Aug; 21(5):884-891. PubMed ID: 33773918
[TBL] [Abstract][Full Text] [Related]
16. Is Pancreatic Head Cancer with Portal Venous Involvement Really Borderline Resectable? Appraisal of an Upfront Surgery Series.
Ohgi K; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Aramaki T; Uesaka K
Ann Surg Oncol; 2017 Sep; 24(9):2752-2761. PubMed ID: 28685356
[TBL] [Abstract][Full Text] [Related]
17. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
18. Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas.
Nagakawa T; Kobayashi H; Ueno K; Ohta T; Kayahara M; Miyazaki I
Cancer; 1994 Feb; 73(4):1155-62. PubMed ID: 8313317
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
20. Proposing the lymphatic target volume for elective radiation therapy for pancreatic cancer: a pooled analysis of clinical evidence.
Sun W; Leong CN; Zhang Z; Lu JJ
Radiat Oncol; 2010 Apr; 5():28. PubMed ID: 20398316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
